Clinical Trial Update: A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia [Phase 2]

View source ↗

Summary

This document reports a Phase II clinical trial evaluating Faropenem for adult community-acquired pneumonia, with the trial status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Faropenem (faropenem)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Community Acquired Pneumonia | Phase 2 | Status: COMPLETED